Morgan Stanley Surgalign Holdings, Inc. Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.18 - $1.65 $571 - $5,235	-3,173 Reduced 8.72%	33,226 $5,000
Q4 2022 Feb 14, 2023	BUY	$1.36 - $3.9 $14 - $42	11 Added 0.03%	36,399 $72,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $6.0 $28,107 - $56,028	-9,338 Reduced 20.42%	36,388 $127,000
Q2 2022 Aug 15, 2022	BUY	$3.38 - $9.0 $154,553 - $411,534	45,726 New	45,726 $155,000

Ticker SRGA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,746,500
Market Cap $67.5K
Description
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.